{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:24:53Z","timestamp":1790702693060,"version":"4.1.0"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,6,28]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to elucidate the clinical factors associated with acute exacerbation and disease progression in young patients with chronic obstructive pulmonary disease (COPD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective longitudinal observational study included patients with COPD aged between 20 and 50 years with post-bronchodilator forced expiratory volume in one second (FEV<jats:sub>1<\/jats:sub>)\/forced vital capacity (FVC)&lt;0.7. Eligible patients were followed up with \u22652 spirometry examinations at 1\u2009year interval after COPD diagnosis. The primary outcome was moderate-to-severe acute exacerbation in young patients with COPD. Secondary outcomes were early initiation of regular inhalation therapy and accelerated annual post-bronchodilator FEV<jats:sub>1<\/jats:sub> decline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 342 patients were followed up during a median of 64 months. In multivariable analyses, risk factors for moderate-to-severe exacerbation were history of asthma (adjusted HR (aHR)=2.999, 95% CI=[2.074\u20134.335]), emphysema (aHR=1.951, 95% CI=[1.331\u20132.960]), blood eosinophil count &gt;300\/\u00b5L (aHR=1.469, 95% CI=[1.038\u20132.081]) and low FEV<jats:sub>1<\/jats:sub> (%) (aHR=0.979, 95% CI=[0.970\u20130.987]). A history of asthma, sputum, blood eosinophil count &gt;300\/\u00b5L, low FEV<jats:sub>1<\/jats:sub> (%) and low diffusing capacity of the lung for carbon monoxide (DL<jats:sub>CO<\/jats:sub>) (%) were identified as clinical factors associated with the early initiation of regular inhalation therapy. The risk factors associated with worsened FEV<jats:sub>1<\/jats:sub> decline were increasing age, female sex, history of pulmonary tuberculosis, sputum, low FEV<jats:sub>1<\/jats:sub> (%) and low DL<jats:sub>CO<\/jats:sub> (%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In young COPD patients, specific high-risk features of acute exacerbation and disease progression need to be identified, including a history of previous respiratory diseases, current respiratory symptoms, blood eosinophil counts, and structural or functional pulmonary impairment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-001740","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T14:15:14Z","timestamp":1721225714000},"page":"e001740","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Risk factors of acute exacerbation and disease progression in young patients with COPD"],"prefix":"10.1136","volume":"11","author":[{"given":"Juye","family":"Bae","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Yong","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Kyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yun","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Heo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deog Kyeom","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-0260","authenticated-orcid":false,"given":"Hyun Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Dongjak-gu, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"2025083110271002000_11.1.e001740.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31222-9"},{"key":"2025083110271002000_11.1.e001740.2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Gold report. 2023."},{"key":"2025083110271002000_11.1.e001740.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411532"},{"key":"2025083110271002000_11.1.e001740.4","doi-asserted-by":"crossref","unstructured":"Cos\u00edo BG , Pascual-Guardia S , Borras-Santos A , et al . Phenotypic characterisation of early COPD: a prospective case-control study. ERJ Open Res 2020;6. doi:10.1183\/23120541.00047-2020","DOI":"10.1183\/23120541.00047-2020"},{"key":"2025083110271002000_11.1.e001740.5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1164\/rccm.202003-0532OC","article-title":"Importance of early COPD in young adults for development of clinical COPD: findings from the copenhagen general population study","volume":"203","author":"\u00c7olak","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110271002000_11.1.e001740.6","doi-asserted-by":"crossref","unstructured":"Wang Z , Li Y , Lin J , et al . Prevalence, risk factors, and mortality of COPD in young people in the USA: results from a population-based retrospective cohort. BMJ Open Respir Res 2023;10. doi:10.1136\/bmjresp-2022-001550","DOI":"10.1136\/bmjresp-2022-001550"},{"key":"2025083110271002000_11.1.e001740.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60446-3"},{"key":"2025083110271002000_11.1.e001740.8","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201100627"},{"key":"2025083110271002000_11.1.e001740.9","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/rccm.201710-2028PP","article-title":"At the root: defining and halting progression of early chronic obstructive pulmonary disease","volume":"197","author":"Martinez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110271002000_11.1.e001740.10","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.112136"},{"key":"2025083110271002000_11.1.e001740.11","doi-asserted-by":"crossref","unstructured":"Lu Z , Coll P , Maitre B , et al . Air pollution as an early determinant of COPD. Eur Respir Rev 2022;31. doi:10.1183\/16000617.0059-2022","DOI":"10.1183\/16000617.0059-2022"},{"key":"2025083110271002000_11.1.e001740.12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1164\/rccm.202205-1000PP","article-title":"Pharmacotherapy and mortality in chronic obstructive pulmonary disease","volume":"206","author":"Halpin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110271002000_11.1.e001740.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00208613"},{"key":"2025083110271002000_11.1.e001740.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025083110271002000_11.1.e001740.15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.202107-1663SO","article-title":"Treatment trials in young patients with chronic obstructive pulmonary disease and pre-chronic obstructive pulmonary disease patients: time to move forward","volume":"205","author":"Martinez","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110271002000_11.1.e001740.16","first-page":"57","article-title":"Spirometric standards for healthy nonsmoking adults","volume":"103","author":"Morris","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"2025083110271002000_11.1.e001740.17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1159\/000525871","article-title":"Risk factors of rapid FEV1 decline in a real-world chronic obstructive pulmonary disease cohort","volume":"101","author":"Lee","year":"2022","journal-title":"Respir"},{"key":"2025083110271002000_11.1.e001740.18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025083110271002000_11.1.e001740.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.07.016"},{"key":"2025083110271002000_11.1.e001740.20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa2204752","article-title":"Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function","volume":"387","author":"Han","year":"2022","journal-title":"N Engl J Med"},{"key":"2025083110271002000_11.1.e001740.21","first-page":"362","article-title":"Is chronic obstructive pulmonary disease really a progressive disease?","volume":"53","author":"de Torres","year":"2017","journal-title":"Arch Bronconeumol (Eng Ed)"},{"key":"2025083110271002000_11.1.e001740.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105482"},{"key":"2025083110271002000_11.1.e001740.23","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00002610"},{"key":"2025083110271002000_11.1.e001740.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200712-1869OC"},{"key":"2025083110271002000_11.1.e001740.25","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1007\/s12325-023-02583-1","article-title":"DElaying disease progression in COPD with early initiation of dual bronchodilator or triple inhaled pharmacotherapy (DEPICT): a predictive modelling approach","volume":"40","author":"Singh","year":"2023","journal-title":"Adv Ther"},{"key":"2025083110271002000_11.1.e001740.26","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.08016"},{"key":"2025083110271002000_11.1.e001740.27","doi-asserted-by":"crossref","unstructured":"Benson VS , Hartl S , Barnes N , et al . Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis. Eur Respir J 2022;59. doi:10.1183\/13993003.04590-2020","DOI":"10.1183\/13993003.04590-2020"},{"key":"2025083110271002000_11.1.e001740.28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3904\/kjim.2021.180","article-title":"Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma","volume":"36","author":"Li","year":"2021","journal-title":"Korean J Intern Med"},{"key":"2025083110271002000_11.1.e001740.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02144-0","article-title":"Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease","volume":"23","author":"Jo","year":"2022","journal-title":"Respir Res"},{"key":"2025083110271002000_11.1.e001740.30","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.2147\/COPD.S278981","article-title":"Characteristics associated with accelerated lung function decline in a primary care population with chronic obstructive pulmonary disease","volume":"15","author":"Whittaker","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110271002000_11.1.e001740.31","article-title":"Rate of FVC decline in a primary care UK chronic obstructive pulmonary disease (COPD) population","volume":"54","author":"Whittaker","year":"2019","journal-title":"Eur Respir J"},{"key":"2025083110271002000_11.1.e001740.32","doi-asserted-by":"crossref","unstructured":"Wijnant SRA , De Roos E , Kavousi M , et al . Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam study. Eur Respir J 2020;55. doi:10.1183\/13993003.01217-2019","DOI":"10.1183\/13993003.01217-2019"},{"key":"2025083110271002000_11.1.e001740.33","doi-asserted-by":"crossref","DOI":"10.1177\/14799731211056340","article-title":"Diffusing capacity in chronic obstructive pulmonary disease assessment: a meta-analysis","volume":"18","author":"Ni","year":"2021","journal-title":"Chron Respir Dis"},{"key":"2025083110271002000_11.1.e001740.34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-51593-8","article-title":"Diffusing capacity as an independent predictor of acute exacerbations in chronic obstructive pulmonary disease","volume":"14","author":"Park","year":"2024","journal-title":"Sci Rep"},{"key":"2025083110271002000_11.1.e001740.35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/COPD.S116086","article-title":"The role of tuberculosis in COPD","volume":"12","author":"Yakar","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110271002000_11.1.e001740.36","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213808"},{"key":"2025083110271002000_11.1.e001740.37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3346\/jkms.2011.26.2.268","article-title":"The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis","volume":"26","author":"Lee","year":"2011","journal-title":"J Korean Med Sci"},{"key":"2025083110271002000_11.1.e001740.38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00408-023-00597-8","article-title":"Tiotropium in patients with bronchiectasis: a prospective cohort study","volume":"201","author":"Shi","year":"2023","journal-title":"Lung"},{"key":"2025083110271002000_11.1.e001740.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-024-02867-4","article-title":"Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction","volume":"24","author":"Lee","year":"2024","journal-title":"BMC Pulm Med"},{"key":"2025083110271002000_11.1.e001740.40","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/resp.14339","article-title":"Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: post hoc analysis of the impact trial","volume":"27","author":"Thompson","year":"2022","journal-title":"Respirology"},{"key":"2025083110271002000_11.1.e001740.41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18353-y","article-title":"Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"2025083110271002000_11.1.e001740.42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4046\/trd.2020.0026","article-title":"Blood eosinophil counts in chronic obstructive pulmonary disease: a biomarker of inhaled corticosteroid effects","volume":"83","author":"Singh","year":"2020","journal-title":"Tuberc Respir Dis (Seoul)"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-001740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:27:21Z","timestamp":1756661241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7,17]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjresp-2023-001740"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-001740","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}